Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2009-03-02 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LAON (02000), Aisne
SELARL PHARMACIE DE LA GARE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE LA GARE is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LAON (02000),
this company of category PME
shows in 2023 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE LA GARE (SIREN 510850209)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
1 666 670 €
1 740 001 €
1 590 667 €
1 624 250 €
1 630 048 €
1 592 986 €
1 663 057 €
1 626 664 €
Net income
29 535 €
16 252 €
37 907 €
44 947 €
63 160 €
105 498 €
132 532 €
124 273 €
124 249 €
EBITDA
N/C
18 091 €
40 936 €
54 155 €
72 714 €
143 540 €
156 848 €
173 670 €
177 816 €
Net margin
N/C
1.0%
2.2%
2.8%
3.9%
6.5%
8.3%
7.5%
7.6%
Revenue and income statement
In 2024, SELARL PHARMACIE DE LA GARE generates positive net income of 30 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 124 k€ -> 30 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
29 535 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
30.751%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
67.729%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE LA GARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
88.911
62.867
43.045
27.648
15.292
39.071
35.838
33.168
30.751
Financial autonomy
47.782
54.828
62.879
69.965
74.652
63.136
64.399
64.906
67.729
Repayment capacity
5.278
4.509
3.313
2.934
2.838
7.072
12.401
18.03
None
Cash flow / Revenue
7.947%
7.475%
8.355%
6.531%
3.957%
3.556%
1.749%
1.18%
None%
Sector positioning
Debt ratio
30.752024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good
In 2024, the debt ratio of SELARL PHARMACIE DE LA GARE (30.75) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
67.73%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of SELARL PHARMACIE DE LA GARE (67.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
18.03 years2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Watch
In 2023, the repayment capacity of SELARL PHARMACIE DE LA GARE (18.03) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 169.34. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
169.343
Liquidity indicators evolution SELARL PHARMACIE DE LA GARE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
195.776
186.103
196.65
178.87
130.6
159.103
159.007
150.602
169.343
Interest coverage
5.805
6.501
3.882
2.732
2.335
0.273
4.004
7.877
None
Sector positioning
Liquidity ratio
169.342024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+12 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DE LA GARE (169.34) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
7.88x2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent+11 pts over 2 years
In 2023, the interest coverage of SELARL PHARMACIE DE LA GARE (7.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE LA GARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
134 330 €
136 969 €
139 243 €
143 086 €
107 785 €
71 819 €
106 018 €
111 850 €
0 €
Inventory turnover (days)
31
34
35
34
37
31
29
31
0
Customer payment term (days)
2
4
1
2
3
0
3
3
0
Supplier payment term (days)
37
37
41
42
38
41
39
43
0
Positioning of SELARL PHARMACIE DE LA GARE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DE LA GARE is estimated at
412 330 €
(range 287 140€ - 616 869€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
287k€412k€616k€
412 330 €Range: 287 140€ - 616 869€
NAF 5 année 2024
Valuation method used
Net Income Multiple
29 535 €
×
14.0x
=412 330 €
Range: 287 140€ - 616 870€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE LA GARE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE LA GARE
What is the revenue of SELARL PHARMACIE DE LA GARE ?
The revenue of SELARL PHARMACIE DE LA GARE in 2023 is 1.7 M€.
Is SELARL PHARMACIE DE LA GARE profitable?
Yes, SELARL PHARMACIE DE LA GARE generated a net profit of 30 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DE LA GARE ?
The headquarters of SELARL PHARMACIE DE LA GARE is located in LAON (02000), in the department Aisne.
Where to find the tax return of SELARL PHARMACIE DE LA GARE ?
The tax return of SELARL PHARMACIE DE LA GARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE LA GARE operate?
SELARL PHARMACIE DE LA GARE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart